Mitochondrial Enzyme ACO2 Protects Lungs from Ischemia-Reperfusion Injury
New research reveals how the enzyme Aconitase-2 shields lung cells from damage during oxygen deprivation and restoration.
Summary
Scientists discovered that Aconitase-2 (ACO2), an enzyme crucial for cellular energy production, protects lungs from ischemia-reperfusion injury. This type of damage occurs when blood flow is restored after oxygen deprivation, common during surgeries or heart attacks. Researchers found that patients with lung injury had lower ACO2 levels, and boosting this enzyme in mice prevented lung damage by maintaining mitochondrial function and preventing cell death. The study suggests ACO2 could be a therapeutic target for protecting organs during medical procedures that temporarily cut off blood supply.
Detailed Summary
Lung ischemia-reperfusion injury occurs when blood flow returns to oxygen-starved lung tissue, causing severe damage through mitochondrial dysfunction and cell death. This condition affects patients during lung transplants, cardiac surgeries, and other medical procedures, making effective treatments critically important for patient outcomes.
Researchers studied 113 participants (65 healthy individuals and 48 patients with lung injury) plus conducted extensive laboratory experiments using mice and isolated lung cells. They used advanced genetic sequencing, engineered viruses to boost ACO2 levels, and tested various interventions to understand how this mitochondrial enzyme affects lung protection.
The study revealed that patients with lung injury had significantly lower blood ACO2 levels, which correlated with worse lung function. In mice, increasing ACO2 expression protected against lung damage, while blocking the enzyme worsened injury. At the cellular level, ACO2 enhanced mitochondrial energy production and prevented programmed cell death in lung blood vessel cells.
These findings suggest ACO2 could become a therapeutic target for preventing organ damage during medical procedures. The research also identified 4-octyl itaconate, a metabolite related to ACO2 function, as a potential protective compound. For longevity and health optimization, this work highlights the critical importance of mitochondrial health in protecting organs from oxidative stress and maintaining cellular resilience.
However, this research was conducted primarily in laboratory settings and animal models. Human clinical trials would be needed to confirm therapeutic applications, and the long-term effects of ACO2 manipulation remain unknown.
Key Findings
- Patients with lung injury showed significantly lower blood ACO2 levels correlating with impaired lung function
- Boosting ACO2 in mice prevented lung damage by maintaining mitochondrial energy production
- ACO2 protects lung blood vessel cells from programmed cell death during oxygen stress
- 4-octyl itaconate supplementation rescued cells from ACO2 deficiency-induced damage
Methodology
Study included 113 human participants (65 healthy, 48 with lung injury) and used mouse models with genetic ACO2 manipulation. Researchers employed single-cell RNA sequencing, isolated primary lung cells, and tested hypoxia/reoxygenation conditions in laboratory settings.
Study Limitations
Research was primarily conducted in animal models and isolated cells, requiring human clinical trials for validation. Long-term safety and effects of ACO2 manipulation in humans remain unknown.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.